The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Anti-C-reactive protein (CRP) antibody has been introduced as a potential biologic marker in Systemic lupus erythematosus (SLE). The aim of study is to evaluate the level of anti-CRP antibody in patients with SLE. Methods: This study investigated the relationship between levels of anti-CRP antibodies and disease activity markers, such as complement, anti-double-stranded DNA antibody, and SLE disease activity index in 34 patients with SLE. Results: The serum anti-CRP antibody levels of the patients with SLE were significantly higher than those of the healthy controls (11.3 ± 5.6 μg/mL vs. 9.1 ± 2.8 μg/mL). The percentages of the positive anti-CRP antibody were 52.9% in SLE and 27.8% in controls. Disease duration of SLE showed significant correlation with the anti-CRP antibody (r = 0.234, p = 0.026). However no significant relationship was observed between the levels of anti-CRP antibodies and disease activity markers. Conclusions: These data show that the anti-CRP antibody levels of the patients with SLE were significantly higher than those of healthy controls. We observed that the presence of the anti-CRP anti-CRP antibody was not associated with disease activity of SLE.
Abstract
Background/Aims: Anti-C-reactive protein (CRP) antibody has been introduced as a potential biologic marker in Systemic lupus erythematosus (SLE). The aim of study is to evaluate the level of anti-CRP antibody in patients with SLE. Methods: This study investigated the relationship between levels of anti-CRP antibodies and disease activity markers, such as complement, anti-double-stranded DNA antibody, and SLE disease activity index in 34 patients with SLE. Results: The serum anti-CRP antibody levels of the patients with SLE were significantly higher than those of the healthy controls (11.3 ± 5.6 μg/mL vs. 9.1 ± 2.8 μg/mL). The percentages of the positive anti-CRP antibody were 52.9% in SLE and 27.8% in controls. Disease duration of SLE showed significant correlation with the anti-CRP antibody (r = 0.234, p = 0.026). However no significant relationship was observed between the levels of anti-CRP antibodies and disease activity markers. Conclusions: These data show that the anti-CRP antibody levels of the patients with SLE were significantly higher than those of healthy controls. We observed that the presence of the anti-CRP anti-CRP antibody was not associated with disease activity of SLE.
참고문헌 (17)
- Sherer Y, "Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients", Semin Arthritis Rheum, 34, pp.501~537 (2004)[DOI]
- Tan EM, "Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology", Adv Immunol, 44, pp.93~151 (1989)
- Jung JY, "Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus", J Investig Med, 62, pp.890~893 (2014)[DOI]
- Zuniga R, "Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles", Arthritis Rheum, 48, pp.460~470 (2003)[DOI]
- Sjowall C, "Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus", Arthritis Res Ther, 6, pp.R87~R94 (2004)[DOI]
- Tan Y, "Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions", Hum Immunol, 69, pp.840~844 (2008)[DOI]
- Sjowall C, "Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis", Arthritis Res Ther, 11, pp.R188~ (2009)[DOI]
- O'Neill SG, "Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus", Arthritis Rheum, 62, pp.845~854 (2010)[DOI]
- Hochberg MC, "Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus", Arthritis Rheum, 40, pp.1725~ (1997)
- Weening JJ, "The classification of glomerulonephritis in systemic lupus erythematosus revisited", J Am Soc Nephrol, 15, pp.241~250 (2004)[DOI]
- Suh CH, "Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6", Clin Immunol, 119, pp.291~296 (2006)[DOI]
- Suh CH, "Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus", Clin Exp Rheumatol, 19, pp.191~194 (2001)
- Sjowall C, "Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren's syndrome, rheumatoid arthritis or inflammatory bowel disease", J Autoimmun, 19, pp.155~160 (2002)[DOI]
- Rosenau BJ, "Antibodies to C reactive protein", Ann Rheum Dis, 65, pp.674~676 (2006)[DOI]
- Shoenfeld Y, "Autoantibodies against protective molecules. C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus", Ann N Y Acad Sci, 1108, pp.227~239 (2007)[DOI]
- Meyer O, "Anti-CRP antibodies in systemic lupus erythematosus", Joint Bone Spine, 77, pp.384~389 (2010)[DOI]
- Pradhan V, "Anti-C reactive protein antibodies in Indian patients with systemic lupus erythematosus", Indian J Nephrol, 23, pp.434~437 (2013)[DOI]